Company Data
NovaBay Pharmaceuticals Inc.
Ticker
NBY
Current Price
$0.4458 -4.91%
Market Cap
$2.2M
Price Target
Refer to Report
Volume
84.2K
52wk Range
$0.3611 - $44.8
Overview
NovaBay Pharmaceuticals Inc is a biopharmaceutical company. The company develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eyecare market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). NovaBay develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.